ArticleAntimicrobial resistance and infection control2016
Carriage of ESBL/AmpC-producing or ciprofloxacin non-susceptible
Article in Antimicrobial resistance and infection control, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.
- Transmission routes of antibiotic resistant bacteria: a systematic review.BMC infectious diseases · 2022Pooled it
- Fluoroquinolone resistance without fluoroquinolone use; the genie is truly out of the bottle.Frontiers in microbiology · 2026Review
- Antimicrobial resistance and vaccines in Enterobacteriaceae including extraintestinal pathogenic Escherichia coli and Klebsiella pneumoniae.npj antimicrobials and resistance · 2025Review
- Nanopore R10.4 metagenomic detection of blaNature communications · 2024Article
- Comparative genomics of quinolone-resistant Escherichia coli from broilers and humans in Norway.BMC microbiology · 2024Article
- Resistome Analysis ofMicroorganisms · 2024Article
- Antimicrobial Resistance Profiles ofVeterinary medicine international · 2024Article
- European Wild Carnivores and Antibiotic Resistant Bacteria: A Review.Antibiotics (Basel, Switzerland) · 2023Review
- Community carriage of ESBL-producingmSphere · 2023Article
- Profiling of antibiotic resistance among uropathogens isolated from patients attending Kericho County Referral Hospital.The Pan African medical journal · 2023Article
- Exploring the Antibiotic Resistance Profile of ClinicalAntibiotics (Basel, Switzerland) · 2022Article
- Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producingJAC-antimicrobial resistance · 2022Review
- Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.PloS one · 2021Article
- Article
- Characteristics of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae and Contact to Animals in Estonia.Microorganisms · 2020Article
- Characterizing Antimicrobial ResistantFrontiers in microbiology · 2020Article
- Characterization of Phenotypic and Genotypic Traits ofInfection and drug resistance · 2020Article
- Composition of the intestinal microbiota in extended-spectrum β-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand.International journal of antimicrobial agents · 2019Article
- Prevalence of faecal carriage of extended-spectrum β-lactamase (ESBL)-producingVeterinary record open · 2019Article
- What does the fox say? Monitoring antimicrobial resistance in the environment using wild red foxes as an indicator.PloS one · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAsymptomatic carriage has been recognised as an important risk factor for infection caused by antibiotic resistant bacteria. A 14% global prevalence of Extended-Spectrum Beta-lactamase (ESBL) carriage was recently reported, but large intra-and interregional variations were observed. We investigated the faecal carriage rates of ESBL-, AmpC-producing and ciprofloxacin non-susceptible
methodsRectal samples were obtained from 284 volunteers, together with demographic data and information on recent travel history. The rectal samples were screened by selective plating and
resultsESBL- or AmpC-producing
conclusionsOverall, our study recognised Norway as a low-incidence country for faecal carriage of resistant bacteria among healthy individuals. Furthermore, our work denoted the importance of healthy humans as a reservoir for transmission of antibiotic resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.